Ask AI

HER2 Horizons: Bridging Innovation and Practice in HER2-Positive NSCLC Treatment

Enhance your ability to accurately identify and manage HER2-overexpressing NSCLC by integrating emerging data on HER2-directed therapies and evidence-based strategies to improve patient care through a certified interactive case challenge, expert-written ClinicalThought commentary, and downloadable slides.

Share

Program Content

Activities

HER2 Positive NSCLC
HER2-Positive NSCLC Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2026

Activities

HER2 Overexpression NSCLC Case
Case Challenge: Treatment Strategies for a 72-Year-Old Woman With Newly Diagnosed HER2-Overexpression and PD-L1–Positive Metastatic NSCLC
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2026

Expires: February 24, 2027

Activities

HER2 Overexpression NSCLC
HER2 Overexpression in NSCLC: From Testing to Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 26, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.